Med Student Medical News about Risk Uterine Neoplasms Fertility Agents

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Use of Antiemetic Agents in Acute Gastroenteritis

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Use of Fertility Drugs and Risk of Uterine Cancer: Results From a Large Danish Population-based Cohort Study
American Journal of Epidemiology, 11/04/09

Jensen A et al. – Ever use of any fertility drug was not associated with uterine cancer risk. However, ever use of gonadotropins (follicle–stimulating hormone and human menopausal gonadotropin) increased uterine cancer risk; the risk was primarily observed after 10 years of follow–up. Furthermore, uterine cancer risk increased with number of cycles of use for clomiphene and human chorionic gonadotropin but not for other gonadotropins. Use of gonadotropin–releasing hormone analogs was not associated with risk. Gonadotropins, and possibly clomiphene and human chorionic gonadotropin, may increase the risk of uterine cancer, with higher doses and longer follow–up leading to greater risk.